|
1
|
U.S. National Cancer Institute:
Surveillance, Epidemiology, and End Results Program. SEER Stat Fact
Sheets: Lung and Bronchus Cancer. http://seer.cancer.gov/statfacts/html/lungb.htmlAccessed.
April 14–2015
|
|
2
|
U.S. National Cancer Institute: Targeted
Cancer Therapies. http://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheetAccessed.
April 12–2015
|
|
3
|
U.S. Food and Drug Administration (FDA):
Search Orphan Drug Designations and Approvals. http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfmAccessed.
April 14–2015
|
|
4
|
Jain PK: Coumarin: Chemical and
pharmacological profile. J App Pharm Sci. 2:236–240. 2012.
|
|
5
|
Casley-Smith JR and Casley-Smith JR: The
pathophysiology of lymphedema and the action of benzo-pyrones in
reducing it. Lymphology. 21:190–194. 1988.PubMed/NCBI
|
|
6
|
Thornes RD, Lynch G and Seehan MV:
Cimetidine and coumarin therapy of melanoma. Lancet. 2:3281982.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cox D, O'Kennedy R and Thornes RD: The
rarity of liver toxicity in patients treated with coumarin
(1,2-benzopyrone). Hum Toxicol. 8:501–506. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thornes D, Daly L, Lynch G, Browne H,
Tanner A, Keane F, O'Loughlin S, Corrigan T, Daly P and Edwards G:
Irish Melanoma Group: Prevention of early recurrence of high risk
malignant melanoma by coumarin. Eur J Surg Oncol. 15:431–435.
1989.PubMed/NCBI
|
|
9
|
Dexeus FH, Logothetis CJ, Sella A, Fitz K,
Amato R, Reuben JM and Dozier N: Phase II study of coumarin and
cimetidine in patients with metastatic renal cell carcinoma. J Clin
Oncol. 8:325–329. 1990.PubMed/NCBI
|
|
10
|
Mohler JL, Gomella LG, Crawford D, Glode
LM, Zippe CD, Fair WR and Marshal ME: Phase II evaluation of
coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma.
Prostate. 20:123–131. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chu CY, Tsai YY, Wang CJ, Lin WL and Tseng
TH: Induction of apoptosis by esculetin in human leukemia cells.
Eur J Pharmacol. 416:25–32. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lopez-Gonzalez JS, Prado-Garcia H,
Aguilar-Cazares D, Molina-Guarneros JA, Morales-Fuentes J and
Mandoki JJ: Apoptosis and cell cycle disturbances induced by
coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines.
Lung Cancer. 43:275–283. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang JY, Della-Fera MA and Baile CA:
Esculetin induces mitochondria-mediated apoptosis in 3T3-L1
adipocytes. Apoptosis. 11:1371–1378. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chuang JY, Huang YF, Lu HF, Ho HC, Yang
JS, Li TM, Chang NW and Chung JG: Coumarin induces cell cycle
arrest and apoptosis in human cervical cancer HeLa cells through a
mitochondria- and caspase-3 dependent mechanism and NF-kappaB
down-regulation. Vivo. 21:1003–1009. 2007.
|
|
15
|
Alvarez-Delgado C, Reyes-Chilpa R, Estrada
Muñiz E, Mendoza-Rodríguez A, Quintero-Ruiz A, Solano J and Cerbón
MA: Coumarin A/AA induces apoptosis-like cell death in HeLa cells
mediated by the release of apoptosis-inducing factor. J Biochem Mol
Toxicol. 23:263–272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Jiang G, Yao F, He Y, Liang G,
Zhang Y, Hu B, Wu Y, Li Y and Liu H: Growth inhibition and
apoptosis induced by osthole, a natural coumarin, in hepatocellular
carcinoma. PLoS One. 7:e378652012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng SY, Li Y, Jiang D, Zhao J and Ge JF:
Anticancer effect and apoptosis induction by quercetin in the human
lung cancer line A-549. Mol Med Rep. 5:822–826. 2012.PubMed/NCBI
|
|
18
|
Shokoohinia Y, Hosseinzadeh L, Alipour M,
Mostafaie A and Mohammadi-Motlagh HR: Comparative evaluation of
cytotoxic and apoptogenic effects of several coumarins on human
cancer cell lines: Osthole induces apoptosis in p53-deficient H1299
cells. Adv Pharmacol Sci. 2014:8475742014.PubMed/NCBI
|
|
19
|
Finn G, Creaven B and Egan D: Modulation
of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin
mediated apoptosis in renal carcinoma cells. Eur J Pharmacol.
481:159–167. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Musa MA, Badisa VL, Latinwo LM, Patterson
TA and Owens MA: Coumarin-based benzopyranone derivatives induced
apoptosis in human lung (A549) cancer cells. Anticancer Res.
32:4271–4276. 2012.PubMed/NCBI
|
|
21
|
Goel A, Prasad AK, Parmar VS, Ghosh B and
Saini N: Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and
7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma
cell line: Role of NF-kappa B, Akt, ROS and MAP kinase pathway.
Chem Biol Interact. 179:363–374. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goel A, Chhabra R, Ahmad S, Prasad AK,
Parmar VS, Ghosh B and Saini N: DAMTC regulates cytoskeletal
reorganization and cell motility in human lung adenocarcinoma cell
line: An integrated proteomics and transcriptomics approach. Cell
Death Dis. 3:e4022012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schilling WH, Crampton RF and Longland RC:
Metabolism of coumarin in man. Nature. 221:664–665. 1969.
View Article : Google Scholar
|
|
24
|
Mossman T: Rapid colorimetric assay for
cellular growth and survival: Applications to proliferation and
cytotoxicity assay. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y: Single-cell microinjection
technologies. Single-cell Analysis: Methods and Protocols.
Lindström S and Andersson-Svahn H: (Heidelberg). Humana Press.
169–176. 2012. View Article : Google Scholar
|
|
26
|
Elinos-Báez CM, León F and Santos E:
Effects of coumarin and 7-OH-coumarin on bcl-2 and Bax expression
in two human lung cancer cell lines in vitro. Cell Biol Int.
29:703–708. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zlabinger GJ, Nöhammer C, Böhmig GA and
Menzel JE: Mode of action of coumarin in immune cells. J Cancer Res
Clin Oncol. 120(Suppl): S17–S18. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Marshall ME, Mohler JL, Edmonds K,
Williams B, Butler K, Ryles M, Weiss L, Urban D, Bueschen A and
Markiewicz M: An updated review of the clinical development of
coumarin (1,2-benzopyrone) and 7-hydroxycoumarin. J Cancer Res Clin
Oncol. 120(Suppl): S39–S42. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wittgen HG, van den Heuvel JJ, van den
Broek PH, Siissalo S, Groothuis GM, de Graaf IA, Koenderink JB and
Russel FG: Transport of the coumarin metabolite 7-hydroxycoumarin
glucuronide is mediated via multidrug resistance-associated
proteins 3 and 4. Drug Metab Dispos. 40:1076–1079. 2012. View Article : Google Scholar : PubMed/NCBI
|
